BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17071630)

  • 1. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
    Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
    Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
    PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
    Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
    Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
    Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
    Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
    Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami HO; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diepstra A; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JF; Gabbas A; Ghesquières H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van Den Berg A; Van Den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
    Leukemia; 2022 Dec; 36(12):2835-2844. PubMed ID: 36273105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Genetic Factors and Clinical Data in Breast Cancer Highlights the Importance of Breastfeeding and Cancer History.
    Mercês A; da-Silva-Cruz R; Silva CS; Burbano R; Ribeiro-Dos-Santos Â; Cavalcante GC
    Curr Issues Mol Biol; 2023 Sep; 45(10):7933-7943. PubMed ID: 37886944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase polymorphisms and genetic susceptibility to multiple myeloma.
    Hosgood HD; Baris D; Zhang Y; Zhu Y; Zheng T; Yeager M; Welch R; Zahm S; Chanock S; Rothman N; Lan Q
    Hematol Oncol; 2008 Sep; 26(3):148-51. PubMed ID: 18381704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen-driven nucleotide overload triggers mitochondria-centered cell death in phagocytes.
    Schwermann N; Haller R; Koch S; Grassl GA; Winstel V
    PLoS Pathog; 2023 Dec; 19(12):e1011892. PubMed ID: 38157331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Caspases: Key Regulators of Biological Activities and Apoptosis.
    Sahoo G; Samal D; Khandayataray P; Murthy MK
    Mol Neurobiol; 2023 Oct; 60(10):5805-5837. PubMed ID: 37349620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.
    Bouquet L; Bôle-Richard E; Warda W; Neto Da Rocha M; Trad R; Nicod C; Haderbache R; Genin D; Ferrand C; Deschamps M
    Gene Ther; 2023 Sep; 30(9):706-713. PubMed ID: 37173386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
    Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study.
    Edathara PM; Gorre M; Kagita S; Cingeetham A; Annamaneni S; Digumarti R; Satti V
    Gene; 2019; 721S():100002. PubMed ID: 34530993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
    Sargazi S; Abghari AZ; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
    Appl Biochem Biotechnol; 2021 Dec; 193(12):4172-4196. PubMed ID: 34463927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.
    Avrutsky MI; Troy CM
    Front Pharmacol; 2021; 12():701301. PubMed ID: 34305609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study.
    Peng M; Zhao G; Yang F; Cheng G; Huang J; Qin X; Liu Y; Wang Q; Li Y; Qin D
    PLoS One; 2017; 12(3):e0173298. PubMed ID: 28264017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation.
    Shaw BE; Lee F; Krishnamurthy S; Byrne JL; Seedhouse C; Mayor NP; Maldonado-Torres H; Saudemont A; Marsh SG; Madrigal JA; Russell NH
    Bone Marrow Transplant; 2015 Feb; 50(2):237-43. PubMed ID: 25347010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
    Hosnijeh FS; Lan Q; Rothman N; San Liu C; Cheng WL; Nieters A; Guldberg P; Tjønneland A; Campa D; Martino A; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Krogh V; Tumino R; Panico S; Masala G; Weiderpass E; Huerta Castaño JM; Ardanaz E; Sala N; Dorronsoro M; Quirós JR; Sánchez MJ; Melin B; Johansson AS; Malm J; Borgquist S; Peeters PH; Bueno-de-Mesquita HB; Wareham N; Khaw KT; Travis RC; Brennan P; Siddiq A; Riboli E; Vineis P; Vermeulen R
    Blood; 2014 Jul; 124(4):530-5. PubMed ID: 24899624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Mekkaw P; Annamaneni S; Digumarthi RR; Sinha S; Satti V
    Tumour Biol; 2014 Sep; 35(9):8813-22. PubMed ID: 24879622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma.
    Li Q; Lan Q; Zhang Y; Bassig BA; Holford TR; Leaderer B; Boyle P; Zhu Y; Qin Q; Chanock S; Rothman N; Zheng T
    Cancer Causes Control; 2013 Oct; 24(10):1875-84. PubMed ID: 23913011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China.
    Xiao MS; Chang L; Li WL; Du YS; Pan Y; Zhang DF; Wen Y; Luo J; Li XY; Yao YG
    PLoS One; 2013; 8(7):e67577. PubMed ID: 23844036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.